These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 437040)

  • 1. Brominated benzene induction of hepatic porphyria.
    Carlson GP
    Experientia; 1979 Apr; 35(4):513-4. PubMed ID: 437040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene].
    Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):541-54. PubMed ID: 3274026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.
    Doss M; Schermuly E; Koss G
    Ann Clin Res; 1976; 8 Suppl 17():171-81. PubMed ID: 1008488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of porphyrinogenic effect of lindane in rats].
    Vila MC; Aldonatti C; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):69-76. PubMed ID: 2429498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of mammary tumors on hexachlorobenzene-induced porphyria in rats.
    Wainstok de Calmanovici R; Cochón AC; Aldonatti C; Bergoc R; San Martín de Viala LC
    Cancer Lett; 1990 Nov; 55(1):67-73. PubMed ID: 2245412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hepatic tumors caused by diethylnitrosamine on hexachlorobenzene-induced porphyria in rats.
    Wainstok de Calmanovici R; Cochón AC; Zenklusen JC; Aldonatti C; Cabral JR; San Martín de Viale LC
    Cancer Lett; 1991 Jul; 58(3):225-32. PubMed ID: 1649694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexachlorobenzene-induced porphyria in rats--relationship between prophyrin excretion and induction of drug metabolizing liver enzymes.
    Lissner R; Goerz G; Eichenauer MG; Ippen H
    Biochem Pharmacol; 1975 Sep; 24(18):1731-3. PubMed ID: 1191331
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of p-amino-benzoic acid on the hexachlorobenzene induced porphyria in the rat (author's transl)].
    Goerz G; Sick N; Vizethum W; Lissner R; Krieg T
    Arzneimittelforschung; 1980; 30(5):817-21. PubMed ID: 6967322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

  • 10. Alcohol and porphyrin metabolism.
    Doss MO; Kühnel A; Gross U
    Alcohol Alcohol; 2000; 35(2):109-25. PubMed ID: 10787385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurological manifestations of porphyria: a review.
    Becker DM; Kramer S
    Medicine (Baltimore); 1977 Sep; 56(5):411-23. PubMed ID: 329053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biotransformation of hexachlorobenzene and hexafluorobenzene in relation to the induction of porphyria.
    Rietjens IM; Steensma A; Den Besten C; van Tintelen G; Haas J; van Ommen B; van Bladeren PJ
    Eur J Pharmacol; 1995 Dec; 293(4):293-9. PubMed ID: 8748681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
    Smith AG; Francis JE
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental porphyria.
    Sweeney GD
    Clin Dermatol; 1985; 3(2):125-43. PubMed ID: 2851387
    [No Abstract]   [Full Text] [Related]  

  • 16. Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.
    Atchison WD; Peterson RE
    Exp Neurol; 1984 Jul; 85(1):63-8. PubMed ID: 6428932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The porphyrinogenic effects of kryptopyrrole in the rat and the occurrence of urinary kryptopyrrole in human hereditary hepatic porphyria.
    Brodie MJ; Graham DJ; Thompson GG; Moore MR; Goldberg A
    Clin Sci Mol Med; 1976 May; 50(5):431-4. PubMed ID: 1277751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro.
    Schoenfeld N; Epstein O; Atsmon A
    Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the origin of urinary porphyrins in experimental hexachlorobenzene-induced porphyria ].
    Adzharov D
    Biull Eksp Biol Med; 1990 Apr; 109(4):355-7. PubMed ID: 2386827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria.
    Wainstock de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
    Biochem Pharmacol; 1986 Jul; 35(14):2399-405. PubMed ID: 3741545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.